MedTrace Logo

Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study

NCT05940688 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-10-17

Study results available
· View outcomes & findings →

Summary

The P3OPPY Project is one of five projects within the American Heart Association P3 EQUATE Network. The overarching goal of the P3 EQUATE American Heart Association Health Equity Research Network (HERN) is to promote equity in Maternal and Infant Health outcomes by identifying innovative and cost-effective strategies to enhance access to quality health information, care, and experiences during pregnancy, postnatal and postpartum/preconception periods, particularly for Black and under-served populations. Collectively, the investigators will collaborate with pregnant and postpartum individuals and their families, hospitals, and communities to discover ways to reduce racism and social problems that contribute to poor health outcomes.

Conditions

  • Pregnancy
  • Infants
  • Disparities

Interventions

BEHAVIORAL

Digital Health intervention

Health care information delivered via a link in a text message that is then opened in a secure browser.

BEHAVIORAL

Community Health Worker

Health care information delivered via CHW.

BEHAVIORAL

Digital Health Intervention plus Community Health Worker

Health care information delivered via DHI plus CHW

Sponsors & Collaborators

  • American Heart Association

    collaborator OTHER

  • ConnectionHealth

    collaborator UNKNOWN

  • Memora Health

    collaborator UNKNOWN

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Rachel Sinkey, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-17
Primary Completion
2024-06-30
Completion
2024-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05940688 on ClinicalTrials.gov